Jiangxi Aifeimu Pharma Co.,Ltd.with Dapoxetine series, Atorvastatin Calcium, Fluvastatin Sodium, Rosuvastatin Calcium, Pitavastatin Calcium, L-Tryptophan, L-Cysteine HCL Monohydrate and their intermediates as main products.
Based on top technologies, Aifeimu has adopted advanced quality control system from overseas to put strict control on material purchase, production and sales. Advanced testing instruments and perfect testing methods are also employed to ensure the products are in accordan...
View more >>
Basic Information
Business Type: Manufacturer
Product/Service (We Buy): 51 - 100 People
Ownership Type: Corporation/Limited Liability Company
Registered Capital: US$5 Million - US$10 Million
Year Established: 2004
Number of Employees: 51 - 100 People
Trade & Market
Main Markets: North America,Southeast Asia,Mid East,South America,Africa,Eastern Asia,Eastern Europe,Oceania,Western Europe
QA/QC: In House
Number of Production Lines: 6
Number of R&D Staff: 102
Number of QC Staff: Less than 5 People
Total Annual Sales Volume: US$50 Million - US$100 Million
China
Poland 
